Complement receptor C3aR marks heterogeneous tumor‐associated macrophage states associated with improved survival in IDH‐wildtype glioblastoma
Abstract Glioblastomas (GBM), IDH‐wildtype, are highly aggressive brain tumors with poor prognosis and inter‐individual variability despite established prognostic factors such as age, performance status, and MGMT promoter (MGMTp) methylation. Increasing evidence highlights the role of the tumor microenvironment (TME) i...